Bio Farma taps Artes for VLP technology

Germany-based Artes Biotechnology has teamed up with Indonesian vaccine maker Bio Farma to expand use of its virus-like particle (VLP) technology. Bio Farma will use Artes' Metavax VLP technology, a vaccine approach based on modifications to duck hepatitis B virus. Release